Yahoo Web Search

Search results

  1. People also ask

  2. Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least...

  3. Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.

    • Meg Tirrell
    • 2 min
  4. Nov 8, 2023 · The F.D.A. approved Zepbound for people with obesity and for those who are overweight and have at least one obesity-related condition. Tirzepatide is already approved for diabetes under the...

  5. Nov 8, 2023 · Darron Cummings/AP. An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster...

    • Yuki Noguchi
  6. Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...

  1. People also search for